cvs maximum redness relief

Generic: glycerin, naphazoline hci

Labeler: cvs pharmacy, inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name cvs maximum redness relief
Generic Name glycerin, naphazoline hci
Labeler cvs pharmacy, inc.
Dosage Form SOLUTION/ DROPS
Routes
OPHTHALMIC
Active Ingredients

glycerin .5 g/100mL, naphazoline hydrochloride .03 g/100mL

Manufacturer
CVS Pharmacy, Inc.

Identifiers & Regulatory

Product NDC 51316-837
Product ID 51316-837_474514b6-e7c8-a448-e063-6394a90a459f
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M018
Listing Expiration 2026-12-31
Marketing Start 2023-03-24

Pharmacologic Class

Established (EPC)
non-standardized chemical allergen [epc]
Chemical Structure
allergens [cs] glycerol [cs]
Physiologic Effect
increased histamine release [pe] cell-mediated immunity [pe] increased igg production [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51316837
Hyphenated Format 51316-837

Supplemental Identifiers

RxCUI
1235200
UNII
PDC6A3C0OX MZ1131787D
NUI
N0000185370 N0000175629 N0000184306 N0000185001 M0000728 M0009417

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cvs maximum redness relief (source: ndc)
Generic Name glycerin, naphazoline hci (source: ndc)
Application Number M018 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • .5 g/100mL
  • .03 g/100mL
source: ndc
Packaging
  • 1 BOTTLE, DROPPER in 1 BOX (51316-837-01) / 15 mL in 1 BOTTLE, DROPPER
source: ndc

Packages (1)

51316-837-01 1 BOTTLE, DROPPER in 1 BOX (51316-837-01) / 15 mL in 1 BOTTLE, DROPPER

Ingredients (2)

glycerin (.5 g/100mL) naphazoline hydrochloride (.03 g/100mL)

Linked Drug Pages (1)

CVS Maximum Redness Relief ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "474514b6-e7c8-a448-e063-6394a90a459f", "openfda": {"nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "unii": ["PDC6A3C0OX", "MZ1131787D"], "rxcui": ["1235200"], "spl_set_id": ["f70f9fc4-4022-336e-e053-6394a90a4d07"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["CVS Pharmacy, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, DROPPER in 1 BOX (51316-837-01)  / 15 mL in 1 BOTTLE, DROPPER", "package_ndc": "51316-837-01", "marketing_start_date": "20230324"}], "brand_name": "CVS Maximum Redness Relief", "product_id": "51316-837_474514b6-e7c8-a448-e063-6394a90a459f", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Glycerol [CS]", "Increased Histamine Release [PE]", "Increased IgG Production [PE]", "Non-Standardized Chemical Allergen [EPC]"], "product_ndc": "51316-837", "generic_name": "Glycerin, Naphazoline HCI", "labeler_name": "CVS Pharmacy, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "CVS Maximum Redness Relief", "active_ingredients": [{"name": "GLYCERIN", "strength": ".5 g/100mL"}, {"name": "NAPHAZOLINE HYDROCHLORIDE", "strength": ".03 g/100mL"}], "application_number": "M018", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20230324", "listing_expiration_date": "20261231"}